Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585741 · ClinicalTrials.gov registry record · NA
Pilot Study of 18F-FLT PET
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00585741 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants.
The verdict
NCT00585741, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Fractionated radiotherapy induces an observable change in the proliferative activity as assessed by pre-treatment and early-treatment 18F-FLT PET imaging. This study is designed to investigate 18F-FLT as a PET imaging agent for predicting treatment effectiveness in several tumors and will serve as a pilot study to a planned PO1 submission
Interventions
- PROCEDURE Imaging with 18F-FLT PET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-12 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585741
The ClinicalTrials.gov registry entry for NCT00585741 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Imaging with 18F-FLT PET is the first listed.
NCT00585741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585741 about?
NCT00585741 is a clinical study titled "Pilot Study of 18F-FLT PET". Fractionated radiotherapy induces an observable change in the proliferative activity as assessed by pre-treatment and early-treatment 18F-FLT PET imaging. This study is designed to investigate 18F-FLT as a PET imaging agent for predicting treatment effectiveness in several tumors and will serve as a...
What is the current status of trial NCT00585741?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2006-12. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00585741?
The interventions under investigation include: Imaging with 18F-FLT PET (PROCEDURE).
Who is sponsoring clinical trial NCT00585741?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.